AAN 2023

Atogepant helps prevent treatment-resistant episodic migraine

Presented By

Dr Patricia Pozo-Rosich, University Hospital Vall d'Hebron, Spain

Trial

Phase 3, ELEVATE

Conference

AAN 2023

2 May, 2023 12:12

Simultaneous head-to-head comparison of 25 migraine medications

Conference

AAN 2023

2 May, 2023 12:09

Donanemab shows rapid and deep plaque clearance in early Alzheimer’s disease

Presented By

Prof. Stephen Salloway, Brown University, USA

Trial

TRAILBLAZER-ALZ 4

Conference

AAN 2023

2 May, 2023 12:07

Continuous levodopa/carbidopa infusion shows favourable safety and efficacy

Presented By

Dr Aaron Ellenbogen , Michigan Institute for Neurological Disorders, USA

Trial

BeyoND

Conference

AAN 2023

2 May, 2023 12:05

EVT improves functional outcomes in Chinese patients with BAO

Presented By

Dr Raul Nogueira, Grady Memorial Hospital, GA, USA

Trial

ATTENTION

Conference

AAN 2023

2 May, 2023 12:03

Allogenic T cell-based immunotherapy for the treatment of PML in development

Presented By

Dr George Ambalathingal, QIMR Berghofer Medical Research Institute, Australia

Conference

AAN 2023

2 May, 2023 12:01

Teriflunomide prevents conversion to MS in patients with RIS

Presented By

Dr Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France

Trial

Phase 3, TERIS

Conference

AAN 2023

1 May, 2023 12:33

Stem cell therapy improves walking in more advanced progressive MS

Conference

AAN 2023

1 May, 2023 12:30

Pridopidine fails to meet the primary endpoint in Huntington’s Disease

Presented By

Prof. Andrew Feign, NYU Grossman School of Medicine, USA

Trial

Phase 3, PROOF-HD

Conference

AAN 2023

1 May, 2023 12:25

Ravulizumab effective in AQP4+ NMOSD

Presented By

Dr Sean Pittock, Mayo Clinic, USA

Trial

Phase 3, CHAMPION-NMOSD

Conference

AAN 2023

1 May, 2023 12:15

Gold nanocrystals may be effective as adjunctive MS therapy

Presented By

Prof. Michael Barnett, University of Sydney, Australia

Trial

SIONARY-MS

Conference

AAN 2023

1 May, 2023 12:12

Encouraging first results of GABAergic interneurons for focal epilepsy

Presented By

Dr David Spencer, Oregon Health & Science University in Portland, USA

Conference

AAN 2023

28 April, 2023 16:55

First-ever ALS platform trial reports on outcomes of 4 treatments

Presented By

Prof. Sabrina Paganoni, Massachusetts General Hospital, USA

Trial

HEALEY ALS Platform

Conference

AAN 2023

28 April, 2023 16:52

Zavegepant nasal spray exhibits good efficacy and safety in acute migraine

Presented By

Prof. Richard Lipton, Albert Einstein College of Medicine, USA

Trial

Phase 3

Conference

AAN 2023

28 April, 2023 16:50

Original antigenic sin influences humoral immune response to SARS-CoV-2

Conference

AAN 2023

28 April, 2023 16:47

Lecanemab may slow decline of cognition and function in AD

Presented By

Prof. Christopher van Dyck, Yale School of Medicine, USA

Trial

CLARITY AD

Conference

AAN 2023

28 April, 2023 16:44

Spinal cord stimulation eases painful diabetic neuropathy

Presented By

Dr Erika Petersen, University of Arkansas, USA

Conference

AAN 2023

28 April, 2023 16:41